(Q43230598)
Statements
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome (English)
Christie M Ballantyne
Jean-Claude Tardif
Gregory G Schwartz
Anders G Olsson
Phillip J Barter
Ingar M Holme
David Kallend
Lawrence A Leiter
Eran Leitersdorf
Prediman K Shah
Bernard R Chaitman
Regina Duttlinger-Maddux
John Mathieson
dal-OUTCOMES Committees and Investigators
1 December 2009